Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04891510 · ClinicalTrials.gov registry record · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
A NA study of Breast Reconstruction and Mastectomy, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 135
- Enrollment target
- 1
- Study location
NCT04891510: Recruiting NA study of Breast Reconstruction and Mastectomy, sponsored by Weill Medical College of Cornell University.
NCT04891510 is a NA study of Breast Reconstruction and Mastectomy that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 135 participants, below the 386-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04891510, a NA study of Breast Reconstruction and Mastectomy, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn whether there is a superior fat processing method in terms of graft retention in breast reconstruction after mastectomy.
Primary Outcome
3D volumetric scanning assesses the fat graft retention defined as the ratio of fat remaining at the surgical site at 90 day follow-up to that at pre-operative baseline.
Conditions Studied
Interventions
- DEVICE REVOLVE Advanced Adipose System
- DEVICE LipoGrafter
- PROCEDURE Viality
Study Locations (1)
New York
- New York Presbyterian - Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2021-05-19 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT04891510 shows while recruiting
NCT04891510 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, below the 386-participant average among 18 other Breast Reconstruction trials with a reported enrollment target (65% lower).
The record links to 3 conditions, with Breast Reconstruction appearing as the primary indexed condition, and to 3 interventions - of which REVOLVE Advanced Adipose System is the first listed.
NCT04891510 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04891510 about?
NCT04891510 is a clinical study titled "A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery". The purpose of this study is to learn whether there is a superior fat processing method in terms of graft retention in breast reconstruction after mastectomy.
What is the current status of trial NCT04891510?
This trial is currently recruiting. It is a NA study. The enrollment target is 135 participants. The study started on 2021-05-19. Estimated completion is 2027-01.
What conditions does trial NCT04891510 study?
This clinical trial studies the following conditions: Breast Reconstruction, Mastectomy, Mammaplasty.
What interventions are being tested in trial NCT04891510?
The interventions under investigation include: REVOLVE Advanced Adipose System (DEVICE), LipoGrafter (DEVICE), Viality (PROCEDURE).
Who is sponsoring clinical trial NCT04891510?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04891510 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Reconstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04891510's enrollment target sits among peer trials
135 12th of 18 higher than 7 of 18 other Breast Reconstruction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Reconstruction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study on Pain After Breast Reconstruction
RECRUITING · NA
-
Melodi Matrix™ in Breast Reconstruction
RECRUITING · NA
-
Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction
RECRUITING · NA
-
Pulsed Lavage in Implant-Based Breast Reconstruction
RECRUITING · NA
-
SAVE Trial: SAfe Opioid Use Video Education
RECRUITING · NA
-
Acellular Dermal Matrix Investigation in Breast Reconstruction
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
- NCT05425615 · 135 participants · NA
Language Processing and TMS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI